Randomized trial: Long-acting injectable antipsychotic use by patients with early-phase schizophrenia can significantly delay time to first hospitalization
11 Dec, 2020 | 09:14h | UTCCommentary: Long-Acting Injectable Antipsychotics vs. Usual Care for Early-Phase Schizophrenia – Physician’s Weekly
Commentary on Twitter
RCT: The mean survival time until 1st hospitalization was 613.7 days for patients with schizophrenia treated with aripiprazole once monthly vs. 530.6 days for those treated with usual care (HR=0.56; 0.34- 0.92; NNT=7) https://t.co/i3857D2ULQ
— PfOL (@psychopharmacol) December 5, 2020